1h-imidazo(4,5-b)pyridine has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blattner, C; Bräse, S; Cato, ACB; Cato, L; Cramer von Clausbruch, CA; Fuhr, O; Gourain, V; Gräßle, S; Heneka, YM; Jeselsohn, RM; Jung, N; Kuznik, NC; Maddalo, D; Munuganti, RSN; Neeb, A; Orian-Rousseau, V; Pan, M; Sharp, A; Solozobova, V; Weiss, C | 1 |
| Ahn, KS; Basappa, B; Basappa, S; Lobie, PE; Mohan, AK; Pandey, V; Ravish, A; Sethi, G; Yang, MH | 1 |
| Ahmad, A; Alam, MA; Alam, O; Haider, MR; Husain, A; Iqbal, MA; Khan, SA | 1 |
3 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Breast Neoplasms
| Article | Year |
|---|---|
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.
Topics: Breast Neoplasms; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Female; Humans; Receptors, Estrogen; Tumor Suppressor Protein p53 | 2023 |
Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Phosphorylation; STAT3 Transcription Factor | 2023 |
Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Design; Female; Humans; Imidazoles; Lung Neoplasms; Male; MCF-7 Cells; Molecular Docking Simulation; Prostatic Neoplasms; Pyridines; Rats; Rats, Wistar; Thiazolidines; Toxicity Tests | 2020 |